CB2 Insights Inc News - CBII

CB2 Insights Adds Insurance Industry Veteran Pam Galassini to its Leadership Team

Galassini brings more than 20 years of experience in the Insurance and Payor industry as a former Medco Health...

CB2 Insights Technology Platform Selected by Dharma Pharmaceuticals to Study Real-World Health Outcomes

Dharma will license the Company’s proprietary technology platform “Sail” to use at the point of care within...

CB2 Insights Addresses Massive Healthcare Gap in Florida with its Skylight Direct Primary Care Membership

TORONTO, July 16, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”...

CB2 Insights Announces Quarterly Revenue of $2.93 million for Q1 2020. EBITDA Nears Breakeven.

TORONTO, July 14, 2020 (GLOBE NEWSWIRE) -- CB2 Insights Inc. (“CB2” or the “Company”) (CSE: CBII; OTCQB:...

CB2 Insights Launches Health Pulse – A Monthly Medical Report Studying and Assessing Real-World Health Outcomes

TORONTO, July 09, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”...

CB2 Insights to Host Q1 2020 Earnings Call on July 15, 2020

TORONTO, July 08, 2020 (GLOBE NEWSWIRE) -- CB2 Insights Inc. (“CB2” or the “Company”) (CSE: CBII; OTCQB:...

CB2 Insights Announces Q1 Financial Statements to be filed on or before July 14, 2020

TORONTO, June 29, 2020 (GLOBE NEWSWIRE) -- CB2 Insights Inc. (“CB2” or the “Company”) (CSE: CBII; OTCQB:...

CB2 Insights Announces Record Annual Revenue of $13.4 million for FY 2019 Sequential Growth of 25%

TORONTO, June 18, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE: CBII; OTCQB: CBIIF) (“CB2” or the “Company”...

CB2 Insights Announces Amendments to Promissory Note held by Merida Capital Partners

TORONTO, June 18, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE: CBII; OTCQB: CBIIF) (“CB2” or the “Company”...

CB2 Insights Announces Delay in Filing Annual Financial Statements

TORONTO, June 15, 2020 (GLOBE NEWSWIRE) -- CB2 Insights Inc. (“CB2” or the “Company”) (CSE: CBII; OTCQB:...

CB2 Insights Announces Delay in Filing Financials and Year End 2019 Financial Results Conference Call

TORONTO, June 10, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”...

CB2 Insights Announces Unaudited Profitability in April and Continued Execution of its Business Plan

TORONTO, May 07, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), has...

CB2 Insights Introduces Insurable Medical Services to Patients in the United States with Launch of Skylight Health Group

TORONTO, April 29, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”...

CB2 Insights Completes Purchase of Colorado-based Relaxed Clarity with Surpassed Initial Targets and Provides Additional Corp...

TORONTO, April 20, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”...

CB2 Insights Announces Delay in Filing Under CSA Instrument Governing Relief under COVID-19 Duress

TORONTO, April 15, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

CB2 Insights Inc (CBII)

Professional-Grade Tools, for Individual Investors.

CBII News

CB2 Insights Adds Insurance Industry Veteran Pam Galassini to its Leadership Team

CB2 Insights Technology Platform Selected by Dharma Pharmaceuticals to Study Real-World Health Outcomes

CB2 Insights Addresses Massive Healthcare Gap in Florida with its Skylight Direct Primary Care Membership

CB2 Insights Announces Quarterly Revenue of $2.93 million for Q1 2020. EBITDA Nears Breakeven.

CB2 Insights Launches Health Pulse – A Monthly Medical Report Studying and Assessing Real-World Health Outcomes

CB2 Insights to Host Q1 2020 Earnings Call on July 15, 2020

CB2 Insights Announces Q1 Financial Statements to be filed on or before July 14, 2020

CB2 Insights Announces Record Annual Revenue of $13.4 million for FY 2019 Sequential Growth of 25%

CB2 Insights Announces Amendments to Promissory Note held by Merida Capital Partners

CB2 Insights Announces Delay in Filing Annual Financial Statements

CB2 Insights Announces Delay in Filing Financials and Year End 2019 Financial Results Conference Call

CB2 Insights Announces Unaudited Profitability in April and Continued Execution of its Business Plan

CB2 Insights Introduces Insurable Medical Services to Patients in the United States with Launch of Skylight Health Group

CB2 Insights Completes Purchase of Colorado-based Relaxed Clarity with Surpassed Initial Targets and Provides Additional Corp...

CB2 Insights Announces Delay in Filing Under CSA Instrument Governing Relief under COVID-19 Duress

CBII Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

CB2 Insights Inc (CBII) News

CB2 Insights Inc (CBII)

Professional-Grade Tools, for Individual Investors.

CBII News

CB2 Insights Adds Insurance Industry Veteran Pam Galassini to its Leadership Team

CB2 Insights Technology Platform Selected by Dharma Pharmaceuticals to Study Real-World Health Outcomes

CB2 Insights Addresses Massive Healthcare Gap in Florida with its Skylight Direct Primary Care Membership

CB2 Insights Announces Quarterly Revenue of $2.93 million for Q1 2020. EBITDA Nears Breakeven.

CB2 Insights Launches Health Pulse – A Monthly Medical Report Studying and Assessing Real-World Health Outcomes

CB2 Insights to Host Q1 2020 Earnings Call on July 15, 2020

CB2 Insights Announces Q1 Financial Statements to be filed on or before July 14, 2020

CB2 Insights Announces Record Annual Revenue of $13.4 million for FY 2019 Sequential Growth of 25%

CB2 Insights Announces Amendments to Promissory Note held by Merida Capital Partners

CB2 Insights Announces Delay in Filing Annual Financial Statements

CB2 Insights Announces Delay in Filing Financials and Year End 2019 Financial Results Conference Call

CB2 Insights Announces Unaudited Profitability in April and Continued Execution of its Business Plan

CB2 Insights Introduces Insurable Medical Services to Patients in the United States with Launch of Skylight Health Group

CB2 Insights Completes Purchase of Colorado-based Relaxed Clarity with Surpassed Initial Targets and Provides Additional Corp...

CB2 Insights Announces Delay in Filing Under CSA Instrument Governing Relief under COVID-19 Duress

CBII Discussion

Your Recent History